Abstract:Introduction: There remains a pressing need for a suitable alternative to currently available techniques for tissue engineering. the use of pluripotent stem cells for tissue engineering has thus far required a period of ex vivo differentiation prior to in vivo implantation to avoid the formation of a teratoma. in this study, we set out to differentiate pluripotent cells down an osteogenic lineage in vivo without pre-differentiation through the creation of a novel osteogenic niche. Methods: Human induced pluripotent stem cells (h-iPS) were derived from human adipose-derived stromal cell using the four Yamanaka factors and characterized for pluripotency. Human embryonic stem cells (hESC) were obtained from existing federally mandated cell lines. The ability of h-iPS and hESC to differentiate down an osteogenic lineage was confirmed in vitro through q-PCR, western blotting, and immunocytochemistry. h-iPS and hESC cells were seeded onto an osteogenic micro-niche consisting of a hydroxyapatite-coated osteoinductive scaffold with BMP-2 and implanted into a 4mm critical-sized calvarial defect macro-niche without prior ex-vivo differentiation in athymic mice. Implanted cell viability was followed through bioluminescence and histological analysis using human nuclear antigen. in vivo calvarial defect healing was assessed by microCT and histology. Results: We demonstrate that the implanted h-iPS and hESC cells undergo teratoma formation when placed in vivo either subcutaneously or within the renal capsule. We show that these cells can undergo osteogenic differentiation in vitro, as revealed by an up-regulation of alkaline phosphatase activity, mineralization and numerous gene markers (RUNX2, OCN and ALP) when placed in osteogenic medium. Most importantly, we also demonstrate that pluripotent cells seeded on an osteoconductive scaffold survive and participate in de novo bone formation, contribute to the healing of skeletal defects, and do not form a teratoma as defined by calcification on Micro CT and histological analysis. Conclusions: These data support that an osteogenic micro-niche scaffold placed into a macro-environmental niche of a skeletal defect promotes in vivo-directed pluripotent cell osteogenic differentiation without the formation of a teratoma. We believe this is the first example of directed lineage differentiation of pluripotent cells without teratoma formation in vivo and without a period of ex-vivo pre-differentation. Development of an in vivo model for directed differentiation of pluripotent cells would be important for these cells as we move closer to clinical applications.

Critical-size Calvarial Bone Defects Healing in a Mouse Model with Silk Scaffolds and SATB2-modified Ipscs.

Epigenetically Modified Bone Marrow Stromal Cells in Silk Scaffolds Promote Craniofacial Bone Repair and Wound Healing

Ectopic and in Situ Bone Formation of Adipose Tissue-Derived Stromal Cells in Biphasic Calcium Phosphate Nanocomposite

Murine iPSC-Loaded Scaffold Grafts Improve Bone Regeneration in Critical-Size Bone Defects

Transcription factor and bone marrow stromal cells in osseointegration of dental implants

Introduction of OCT4 into Human Bone-Marrow Derived Mesenchymal Stromal Cells Generates Putative Ips Cells with the Potential to Differentiate into CD34+ Hematopoietic Progenitor Cells Ex Vivo

Roles of SATB2 in site-specific stemness, autophagy and senescence of bone marrow mesenchymal stem cells

Adipose-derived Stem Cell Sheets Combined with Β-Tricalcium Phosphate/collagen-I Fiber Scaffold Improve Cell Osteogenesis.

3D robocasting magnesium-doped wollastonite/TCP bioceramic scaffolds with improved bone regeneration capacity in critical sized calvarial defects

Lentiviral-Mediated Expression of Satb2 Promotes Osteogenic Differentiation of Bone Marrow Stromal Cells in Vitro and in Vivo

Repairing Critical-Sized Calvarial Defects with BMSCs Modified by a Constitutively Active Form of Hypoxia-Inducible Factor-1Α and a Phosphate Cement Scaffold.

[Ectopic Osteogenesis of Stromal Cell-Derived Factor 1 Combined with Simvastatin-Loaded Collagen Scaffold in Vivo].

In Vivo Directed Differentiation of Pluripotent Stem Cells to Bone Lineage and Repair of a Skeletal Defect

Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats

In Vivo Directed Differentiation Of Pluripotent Stem Cells For Skeletal Regeneration

The effects of oyster shell/alpha-calcium sulfate hemihydrate/platelet-rich plasma/bone mesenchymal stem cells bioengineering scaffold on rat critical-sized calvarial defects

Incorporation of Osteogenic and Angiogenic Small Interfering RNAs into Chitosan Sponge for Bone Tissue Engineering.

Restoration of Critical-Sized Defects in the Rabbit Mandible Using Autologous Bone Marrow Stromal Cells Hybridized with Nano-β-tricalcium Phosphate/Collagen Scaffolds

Combining sclerostin neutralization with tissue engineering: An improved strategy for craniofacial bone repair

iPSC-neural crest derived cells embedded in 3D printable bio-ink promote cranial bone defect repair

Reconstruction of Rat Calvarial Defects with Human Mesenchymal Stem Cells and Osteoblast-Like Cells in Poly-Lactic-co-glycolic Acid Scaffolds